###begin article-title 0
###xml 103 106 103 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 137 141 <span type="species:ncbi:10090">Mice</span>
Dysbindin Regulates the Transcriptional Level of Myristoylated Alanine-Rich Protein Kinase C Substrate via the Interaction with NF-YB in Mice Brain
###end article-title 0
###begin p 1
Conceived and designed the experiments: HO SM SM MT. Performed the experiments: HO RK SM. Analyzed the data: HO RK SM SM NK TH RH TK MT. Contributed reagents/materials/analysis tools: SM NK SS KY KK RH MT TK. Wrote the paper: HO RK SM MT.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 124 129 <span type="species:ncbi:4932">yeast</span>
An accumulating body of evidence suggests that Dtnbp1 (Dysbindin) is a key susceptibility gene for schizophrenia. Using the yeast-two-hybrid screening system, we examined the candidate proteins interacting with Dysbindin and revealed one of these candidates to be the transcription factor NF-YB.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 403 407 <span type="species:ncbi:10090">mice</span>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
We employed an immunoprecipitation (IP) assay to demonstrate the Dysbindin-NF-YB interaction. DNA chips were used to screen for altered expression of genes in cells in which Dysbindin or NF-YB was down regulated, while Chromatin IP and Reporter assays were used to confirm the involvement of these genes in transcription of Myristoylated alanine-rich protein kinase C substrate (MARCKS). The sdy mutant mice with a deletion in Dysbindin, which exhibit behavioral abnormalities, and wild-type DBA2J mice were used to investigate MARCKS expression.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 393 396 393 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 494 498 <span type="species:ncbi:10090">mice</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
We revealed an interaction between Dysbindin and NF-YB. DNA chips showed that MARCKS expression was increased in both Dysbindin knockdown cells and NF-YB knockdown cells, and Chromatin IP revealed interaction of these proteins at the MARCKS promoter region. Reporter assay results suggested functional involvement of the interaction between Dysbindin and NF-YB in MARCKS transcription levels, via the CCAAT motif which is a NF-YB binding sequence. MARCKS expression was increased in sdy mutant mice when compared to wild-type mice.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 58 61 58 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
These findings suggest that abnormal expression of MARCKS via dysfunction of Dysbindin might cause impairment of neural transmission and abnormal synaptogenesis. Our results should provide new insights into the mechanisms of neuronal development and the pathogenesis of schizophrenia.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 391 394 391 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Garver1">[1]</xref>
###xml 395 398 395 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Mouri1">[4]</xref>
###xml 421 424 421 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-CATIE1">[5]</xref>
###xml 425 429 425 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Stephan1">[11]</xref>
###xml 72 79 <span type="species:ncbi:9606">patient</span>
Schizophrenia is a common and devastating psychiatric disorder. Lack of patient compliance, due to undesirable side effects and efficacy restricted to positive symptoms, highlights the need to develop novel therapeutics. The etiology of the disease remains unknown, but in recent years a convergence of genetic, pharmacological, and neuroanatomical findings suggest that neural transmission [1]-[4] and synapse formation [5]-[11] are involved in schizophrenia. Recent studies suggest that disturbances of Dysbindin (dystrobrevin-binding protein 1; DTNBP1) are involved in this abnormal neural transmission.
###end p 11
###begin p 12
###xml 204 208 204 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Straub1">[12]</xref>
###xml 210 214 210 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Schwab1">[13]</xref>
###xml 227 231 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Stefansson1">[14]</xref>
###xml 233 237 233 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Stefansson2">[15]</xref>
###xml 247 250 247 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-O-</italic>
###xml 268 272 268 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Egan1">[16]</xref>
###xml 273 277 273 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Shifman1">[18]</xref>
###xml 286 290 286 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Chowdari1">[19]</xref>
###xml 291 295 291 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Morris1">[22]</xref>
###xml 433 437 433 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Wang1">[23]</xref>
###xml 439 443 439 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Straub2">[24]</xref>
###xml 576 580 576 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Benson1">[25]</xref>
###xml 643 647 643 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Straub1">[12]</xref>
The cause of schizophrenia is thought to involve the combined effects of multiple gene components. Genetic linkage and association studies have identified potential susceptibility genes such as Dysbindin [12], [13], Neuregulin [14], [15], Catechol-O-methyltransferase [16]-[18] and RG4 [19]-[22]. In particular, it has been reported that chromosome 6p is one of the highest susceptibility regions in linkage studies of schizophrenia [23], [24]. Among them, genetic variants in a gene 6p22.3 expressing Dysbindin, which is identified as a protein interacting with dystrobevins [25], have been shown to be strongly associated with schizophrenia [12].
###end p 12
###begin p 13
###xml 77 81 77 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Talbot1">[26]</xref>
###xml 91 95 91 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Weickert1">[27]</xref>
###xml 296 300 296 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Talbot1">[26]</xref>
###xml 302 306 302 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Chiba1">[28]</xref>
###xml 650 654 650 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Weickert1">[27]</xref>
###xml 656 660 656 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Bray1">[29]</xref>
###xml 115 123 <span type="species:ncbi:9606">patients</span>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
In studies on postmortem brain tissue, decreased levels of Dysbindin protein [26] and mRNA [27] have been shown in patients with schizophrenia compared with controls. Chronic treatment of mice with antipsychotics did not affect the expression levels of Dysbindin protein and mRNA in their brains [26], [28], suggesting that evidence of lower levels of Dysbindin protein and mRNA in the postmortem brains of schizophrenics is not likely to be a simple artifact of antemortem drug treatment. In addition, previous reports have shown that diverse high-risk single nucleotide polymorphisms (SNPs) and haplotypes could influence Dysbindin mRNA expression [27], [29]. These data indicate that the Dysbindin gene may confer susceptibility to schizophrenia through reduced Dysbindin expression.
###end p 13
###begin p 14
###xml 96 105 96 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysbindin</italic>
###xml 316 320 316 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Corvin1">[30]</xref>
###xml 322 326 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Donohoe1">[31]</xref>
###xml 417 421 417 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Burdick1">[32]</xref>
###xml 422 426 422 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Zinkstok1">[34]</xref>
###xml 592 596 592 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Talbot1">[26]</xref>
###xml 598 602 598 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Sillitoe1">[35]</xref>
###xml 891 895 891 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Numakawa1">[36]</xref>
###xml 1063 1067 1063 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Talbot1">[26]</xref>
###xml 1069 1073 1069 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Weickert1">[27]</xref>
Several lines of evidence suggest that Dysbindin may be associated with brain function. SNPs in Dysbindin have been associated with intermediate cognitive phenotypes related to schizophrenia such as IQ and working and episodic memory, and a Dysbindin haplotype has been associated with higher educational attainment [30], [31]. In addition, several reports suggest the involvement of Dysbindin in cognitive functions [32]-[34]. These findings strongly suggest the importance of Dysbindin in brain function. At the cellular level, Dysbindin is located at both pre- and post-synaptic terminals [26], [35], and is thought to be involved in postsynaptic density (PSD) function and the trafficking of receptors (NMDA, GABAergic, and nicotinic). Over-expression of Dysbindin increases glutamate release from pyramidal neurons in cell culture, possibly because of its role in vesicular trafficking [36]. Decreases in Dysbindin mRNA and protein levels have been reported in regions previously implicated in schizophrenia: the prefrontal cortex, midbrain, and hippocampus [26], [27]. However, the molecular mechanisms of how decreases in Dysbindin expression may contribute to vulnerability to schizophrenia remain unknown.
###end p 14
###begin p 15
###xml 313 319 313 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 552 556 552 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Murotani1">[37]</xref>
###xml 558 562 558 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Hattori1">[38]</xref>
###xml 643 647 643 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Numakawa1">[36]</xref>
###xml 649 653 649 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Kumamoto1">[39]</xref>
###xml 824 830 824 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 921 925 921 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Numakawa1">[36]</xref>
###xml 927 931 927 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Kumamoto1">[39]</xref>
###xml 1052 1056 1052 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Kubota1">[40]</xref>
###xml 1151 1154 1151 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 62 67 <span type="species:ncbi:4932">yeast</span>
###xml 527 531 <span type="species:ncbi:10090">mice</span>
###xml 546 550 <span type="species:ncbi:10090">mice</span>
Thus, we examined the interacting partners of Dysbindin using yeast two-hybrid analysis in order to help elucidate the function of Dysbindin. These interacting-protein data suggest that Dysbindin is involved in such processes as neurotransmission, cell signaling, the cytoskeleton and transcription. (Matsuzaki S et al. in submission). In addition, our previous reports suggest the following; (1) decreased expression of Dysbindin might increase dopamine release in the brain resulting in the observed abnormal behavior in sdy mice (Dysbindin KO mice) [37], [38], (2) Dysbindin is likely involved in dopaminergic or glutamatergic transmission [36], [39], (3) Dysbindin is likely involved in neurotransmission by binding with the BLOC1 complex, and with transcription by binding with transcription-related genes (Matsuzaki S et al. in submission), (4) the expression level of Dysbindin may affect the expression of SNAP25 [36], [39], (5) Dysbindin may play a key role in coordinating JNK signaling and actin cytoskeleton required for neural development [40]. These findings suggest that Dysbindin may influence neurotransmission and neural development via interaction with other factors or by regulation of transcription.
###end p 15
###begin p 16
###xml 167 173 167 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Donati1">[41]</xref>
###xml 379 383 379 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Maity1">[44]</xref>
###xml 483 486 483 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 609 612 609 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
In a previous paper, we identified several Dysbindin interacting partners including the transcription factor, nuclear transcription factor Y beta (NF-YB) (Matsuzaki S et al. in submission). NF-YB belongs to a family of CCAAT-binding transcription factors, which are important for the basal transcription of a class of regulatory genes and are involved in cellular reactions [41]-[44]. Subsequently, in this study, we examined the functional involvement of Dysbindin in transcription via its interaction with NF-YB. As a result, we showed that the NF-YB/Dysbindin complex regulates the transcription of MARCKS via interaction with certain CCAAT sequences, and abnormal NF-YB/Dysbindin interaction could cause alterations such as impaired neural transmission and abnormal development of neurons.
###end p 16
###begin title 17
Results
###end title 17
###begin title 18
Dysbindin Exists within the Nucleus in Addition to the Cytoplasm
###end title 18
###begin p 19
###xml 455 464 455 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g001">Figure 1A</xref>
###xml 581 585 581 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Nian1">[45]</xref>
###xml 788 797 788 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g001">Figure 1B</xref>
###xml 1017 1036 1017 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g001">Figure 1B -c and -d</xref>
We examined the existence of Dysbindin in the nucleus, because Dysbindin should exist within the nucleus to play a functional role in transcriptional regulation. We used an overexpression vector for Dysbindin tagged with -FLAG or -V5 to check the intracellular localization of Dysbindin. The fractionation study using Dysbindin-FLAG-overexpressing HEK293 cells shows that Dysbindin exists mainly in the cytosol while a small amount exists in the nucleus (Figure 1A), and Dysbindin-V5 showed the same results (data not shown). These results are in accordance with a previous report [45]. Morphologically, Dysbindin is localized mainly in the cytoplasm with a perinuclear high density region in HEK293 cells and SY5Y cells; however, a faint immunoreaction was also seen within the nucleus (Figure 1B -a and -b). Furthermore, pretreatment with leptomycine-B (LPB), which inhibits export from the nucleus to the cytoplasm, caused a slight Dysbindin increase in cells, which then showed nuclear localization of Dysbindin (Figure 1B -c and -d ). These findings suggest that Dysbindin protein is shuttled between the nucleus and the cytoplasm.
###end p 19
###begin title 20
The nuclear localization of Dysbindin.
###end title 20
###begin p 21
(A) HEK293 cells overexpressing Dysbindin-FLAG were separated into nuclear and cytosolic fractions. Anti-Bcl2 antibody was used for the cytosolic fraction marker and anti-Histone H3 antibody was used for the nuclear fraction marker. W: Whole cell lysates, N: Nuclear Fraction, C: Cytosolic fraction. Dysbindin-FLAG was slightly present in the nuclear fraction. (B) Dysbindin-GFP was overexpressed in HEK293 cells (a and c) or in SH-SY5Y cells (b and d). Dysbindin was usually localized in the cytoplasm and slightly in the nucleus (a and b). After treatment with LMB, a potent inhibitor of CRM1-dependent nuclear export, Dysbindin-GFP accumulated in the nucleus (c and d).
###end p 21
###begin title 22
Dysbindin Binds to the Transcription Factor NF-YB
###end title 22
###begin p 23
###xml 297 306 297 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g001">Figure 1A</xref>
###xml 659 668 659 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g002">Figure 2A</xref>
###xml 6 11 <span type="species:ncbi:4932">yeast</span>
Using yeast two-hybrid screening, we identified several transcriptional factors as candidates that may interact with Dysbindin. We selected NF-YB, one of the candidates, and confirmed a Dysbindin-NF-YB interaction by immunoprecipitation assay using HEK293T cells which express NF-YB endogenously (Figure 1A). HEK293T cells were transfected with expression vectors for Dysbindin-V5, and cell lysates were subjected to immunoprecipitation with anti-V5 or anti-NF-YB antibodies, followed by Western blot analysis with a reciprocal antibody. NF-YB was detected in the immunoprecipitates with an anti-V5 body, comparing to the immunoprecipitates with control IgG (Figure 2A), while Dysbindin-V5 was detected in the immunoprecipitates with an anti-NF-YB antibody, comparing to control IgG (data not shown). Thus, Dysbindin and NF-YB are physiologically associated with each other in transfected mammalian cells.
###end p 23
###begin title 24
The interaction between Dysbindin and NF-YB.
###end title 24
###begin p 25
###xml 174 176 174 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd</sup>
###xml 218 220 218 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 419 420 416 417 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 524 526 521 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd</sup>
###xml 554 556 551 553 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd</sup>
###xml 598 600 595 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 831 833 828 830 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 879 881 876 878 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 199 205 <span type="species:ncbi:9986">rabbit</span>
###xml 579 585 <span type="species:ncbi:9986">rabbit</span>
(A) HEK293 cells were transfected with Dysbindin-V5. Immunoprecipitates (IP) of lysates of HEK293 cells expressing Dysbindin-V5 obtained by antibodies to tag proteins (V5) (2nd lane), or nonspecific rabbit IgG (IgG) (1st lane) were subjected to Western blot with anti- NF-YB antibody (upper panel). Dilutions of the lysate (5%, HEK293 cells) were subjected to Western blot with anti-beta-actin antibody (lower panel). (B) Immunoprecipitates (IP) of lysates of SH-SY5Y cells obtained by antibodies to Dysbindin (upper panel 2nd lane), NF-YB (lower panel 2nd lane), or nonspecific rabbit IgG (IgG) (1st lane of both panels) were subjected to Western blot with anti- NF-YB antibody (upper panel) or Dysbindin antibody (lower panel). Dilutions of the lysate (5%, HEK293 cells) were subjected to Western blot with anti-NF-YB antibody (3rd lane of upper panel) or Dysbindin antibody (3rd lane of lower panel).
###end p 25
###begin p 26
###xml 277 281 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Kubota1">[40]</xref>
###xml 403 412 403 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g002">Figure 2B</xref>
###xml 415 417 415 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 618 627 618 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g002">Figure 2B</xref>
###xml 630 632 630 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd</sup>
###xml 143 148 <span type="species:ncbi:10090">mouse</span>
###xml 265 270 <span type="species:ncbi:10090">mouse</span>
###xml 703 708 <span type="species:ncbi:10090">mouse</span>
To further our research, we produced a specific anti-Dysbindin antibody with high titer. The antibody detects endogenous Dysbindin in cell and mouse brain samples, though it did not detect any bands corresponding to Dysbindin from the lysates of Dysbindin knockout mouse brain [40]. The existence of endogenous Dysbindin and endogenous NF-YB in lysates from SH-SY5Y cells was confirmed by Western Blot (Figure 2B, 3rd lane of both panels). Immunoprecipitation using the lysates with antibodies for Dysbindin and NF-YB and subsequent Western blot revealed the interaction of endogenous Dysbindin with endogenous NF-YB (Figure 2B, 2nd lane of both panels), and this binding was also confirmed using adult mouse brain lysates (data not shown).
###end p 26
###begin title 27
Downregulation of Dysbindin Causes Upregulation in Expression Levels of Myristoylated Alanine-Rich Protein Kinase C Substrate (MARCKS)
###end title 27
###begin p 28
###xml 383 392 383 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysbindin</italic>
###xml 396 401 396 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF-YB</italic>
###xml 546 555 546 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008773.s001">Figure S1</xref>
###xml 686 694 686 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008773-t001">Table 1A</xref>
###xml 751 759 751 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008773-t001">Table 1B</xref>
###xml 1024 1031 1024 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008773-t001">Table 1</xref>
###xml 1146 1152 1146 1152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MARCKS</italic>
###xml 1154 1158 1154 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Trifar1">[46]</xref>
###xml 1159 1163 1159 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Park1">[48]</xref>
###xml 1189 1194 1189 1194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLCB4</italic>
###xml 1196 1200 1196 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Maejima1">[49]</xref>
###xml 1222 1226 1222 1226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SYT1</italic>
###xml 1228 1232 1228 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Koh1">[50]</xref>
###xml 1474 1478 1474 1478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Manji1">[51]</xref>
###xml 1488 1492 1488 1492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Sokolov1">[52]</xref>
###xml 1585 1589 1585 1589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Sokolov1">[52]</xref>
###xml 1921 1927 1921 1927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MARCKS</italic>
###xml 325 330 <span type="species:ncbi:9606">human</span>
###xml 1576 1584 <span type="species:ncbi:9606">patients</span>
###xml 1654 1662 <span type="species:ncbi:9606">patients</span>
###xml 1730 1738 <span type="species:ncbi:9606">patients</span>
As shown above, we had revealed an interaction between Dysbindin and NF-YB. This result suggests that Dysbindin may be functionally involved in transcription of some genes regulated by NF-YB. We screened for genes displaying altered expression by means of a DNA chip, using RNA extracts from the Dysbindin or NF-YB knockdown human neural cell line, SH-SY5Y. The expression of either Dysbindin or NF-YB was decreased by the corresponding siRNA for each gene, and the effects of siRNA on Dysbindin or NF-YB were confirmed by Western blot analysis (Figure S1). The genes showing increased expression in the Dysbindin knockdown cells, as well as in the NF-YB knockdown cells, are listed in Table 1A, while those showing decreased expression are listed in Table 1B. Next, using the DANASIS 2.0 system or sequencing of the promoter region, we screened for genes having the CCAAT sequence in the promoter region, because NF-YB is known to bind with high specificity to the CCAAT motif in the promoter region of a variety of genes (Table 1, gene names shown in red). We then focused on three genes; Myristoylated alanine-rich protein kinase C substrate (MARCKS) [46]-[48], Phospholipase C beta 4 (PLCB4) [49] and Synaptotagmin 1 (SYT1) [50], because an accumulating number of reports point to the involvement of impaired neural transmission in the schizophrenia pathology. In addition, we considered the involvement of the genes in psychiatric diseases and we narrow down to MARCKS [51] and SYT1 [52]. Interestingly, a previous report suggests the alteration of SYT1 in schizophrenia patients [52]. The paper shows increase of SYT1 mRNA in younger schizophrenia patients group, while it shows decrease of SYT1 mRNA in older schizophrenia patients. These results suggest the complicated and multiple regulation of SYT1 transcriptional regulation. Thus, we examined the functional involvement of the Dysbindin-NF-YB interaction in MARCKS transcription.
###end p 28
###begin title 29
The list of genes altered by Dysbindin as well as NF-YB.
###end title 29
###begin p 30
(A) The genes upregulated by the knockdown of Dysbindin that were in common with those upregulated by the knockdown of NF-YB are listed. The genes showed by bold and italic format have the CCAAT motif.
###end p 30
###begin p 31
(B) The genes downregulated by the knockdown of Dysbindin that were in common with those downregulated by the knockdown of NF-YB are listed. The genes showed by bold and italic format have the CCAAT motif.
###end p 31
###begin p 32
###xml 327 336 327 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g003">Figure 3A</xref>
###xml 384 391 384 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 674 683 674 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g003">Figure 3B</xref>
###xml 895 904 895 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g003">Figure 3B</xref>
###xml 996 1002 996 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MARCKS</italic>
###xml 502 506 <span type="species:ncbi:10090">mice</span>
###xml 547 551 <span type="species:ncbi:10090">mice</span>
###xml 570 574 <span type="species:ncbi:10090">mice</span>
###xml 793 797 <span type="species:ncbi:10090">mice</span>
###xml 889 893 <span type="species:ncbi:10090">mice</span>
To confirm the involvement of the knockdown of Dysbindin or NF-YB in the upregulation of MARCKS, we performed Western blot analysis using Dysbindin or NF-YB knockdown SH-SY5Ycells. Comparing the expression level of the MARCKS protein with that of control cells, Dysbindin knockdown cells showed upregulation of MARCKS protein (Figure 3A). To confirm the effect of Dysbindin on MARCKS in vivo, we examined the expression of MARCKS protein in the hippocampus with advancing age of the Dysbindin knockout mice, comparing with that found in wild-type mice. In the wild-type mice, a peak in MARCKS protein expression in the hippocampus was identified at postnatal day 15 and 20 (Figure 3B), and then decreased markedly over time. However, such a decrease was not observed in the Dysbindin knockout mice, where large amounts of Dysbindin protein were still expressed in the hippocampii of older mice (Figure 3B). These findings suggest that downregulation of Dysbindin may enhance transcription of the MARCKS gene, resulting in the upregulation of MARCKS protein.
###end p 32
###begin title 33
The effects of Dysbindin on MARCKS expression levels.
###end title 33
###begin p 34
###xml 466 467 464 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 980 981 976 977 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1099 1105 1095 1101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MARCKS</italic>
###xml 1164 1166 1160 1162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 1209 1211 1205 1207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd</sup>
###xml 1248 1250 1244 1246 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 548 552 <span type="species:ncbi:10090">mice</span>
###xml 569 573 <span type="species:ncbi:10090">mice</span>
###xml 771 775 <span type="species:ncbi:10090">mice</span>
###xml 843 847 <span type="species:ncbi:10090">mice</span>
(A) SH-SY5Y cells were transfected with scrambled siRNA or siRNA for Dysbindin. Cell lysate of non-treated cells (Cont.), scrambled RNAi-transfected cells (Scr.) and RNAi for Dysbindin-transfected cells (siRNA) were subjected to Western blot with anti-MARCKS antibody. Columns and vertical bars denote the means +/- SEM (triplicate independent experiments). Dysbindin knockdown cells exhibited significant reduction of MARCKS expression compared with control cells (P<0.001, Student's t-test). (B) Hippocampus lysates were collected from wild-type mice or Dysbindin KO mice at P15, P20 and P45. The lysates were subjected to Western blot with anti-MARCKS antibody. Graphs and vertical bars denote the means +/- SEM (triplicate independent experiments). At P45, Wild-type mice showed significant decreased MARCKS expression, while Dysbindin KO mice showed a maintained MARCKS expression. These data were confirmed by triplicate independent experiments (P<0.01, Student's t-test). (C)Chromatin IP (ChIP) was performed using SH-SY5Y cells under the stimulation of retinoic acid. The promoter region of MARCKS was detected both in the IPs of anti-Dysbindin antibody (1st panel) and those of anti-NF-YB antibody (2nd panel), but not in the IPs of IgG (3rd panel).
###end p 34
###begin p 35
###xml 181 191 181 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MARCKS via</italic>
###xml 232 238 232 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MARCKS</italic>
###xml 293 300 293 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MARCKS,</italic>
###xml 474 480 474 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MARCKS</italic>
###xml 536 545 536 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g003">Figure 3C</xref>
###xml 647 653 647 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MARCKS</italic>
###xml 686 692 686 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MARCKS</italic>
We performed chromatin IP analysis using SH-SY5Y cells over-expressing Dysbindin-Flag, to explore the possibility that the Dysbindin-NF-YB complex could affect the transcription of MARCKS via interaction with the promoter region of MARCKS. The cells were stimulated by retinoic acid to induce MARCKS, and were collected as the samples for chromatin IP. PCR products from the chromatin IPs suggest that Dysbindin and NF-YB simultaneously interact with the promoter region of MARCKS, but control IgG experiments did not show this result (Figure 3C). These findings indicate that the Dysbindin-NF-YB complex interacts with the promoter region of the MARCKS gene resulting in inhibition of MARCKS transcription.
###end p 35
###begin title 36
###xml 33 39 33 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MARCKS</italic>
###xml 71 74 71 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
The Transcriptional Level of the MARCKS Gene Is Regulated by Dysbindin via the NF-YB Binding Motif, CCAAT-2
###end title 36
###begin p 37
###xml 12 21 12 21 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g004">Figure 4A</xref>
###xml 48 54 48 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MARCKS</italic>
###xml 462 468 462 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MARCKS</italic>
###xml 655 664 655 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g004">Figure 4A</xref>
###xml 1015 1024 1015 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g004">Figure 4A</xref>
###xml 1271 1280 1271 1280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g004">Figure 4A</xref>
###xml 1405 1414 1405 1414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g004">Figure 4A</xref>
###xml 1503 1509 1503 1509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MARCKS</italic>
###xml 1667 1676 1667 1676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g004">Figure 4A</xref>
###xml 1720 1726 1720 1726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MARCKS</italic>
As shown in Figure 4A, the 5'-UTR region of the MARCKS gene has two kinds of CCAAT sequences; one CCAAT motif located between UTR -1152 and -700 and the other located between UTR -700 and -614. In this study, we tentatively named the former CCAAT sequence "CCAAT-1" and the latter "CCAAT-2." It is well known that NF-YB binds to the CCAAT motif to regulate transcription of target genes. Thus, we examined whether CCAAT motifs are essential to the regulation of MARCKS transcription by means of a luciferase assay, using the following five vectors containing shorter RNA probes; UTR(1152)-Luc, UTR (953)-Luc, UTR(700)-Luc, UTR(614)-Luc, and UTR(462)-Luc (Figure 4A). These constructs were transiently transfected into SH-SY5Y cells which express Dysbindin and NF-YB endogenously, and luciferase activity in each cell line was measured 24 hours after stimulation with retinoic acid. As baseline, we used luciferase activity detected in the SH-SY5Y cells expressing the UTR(1152)-Luc after retinoic acid stimulation (Figure 4A). In the cells transfected with UTR (953)-Luc containing both CCAAT sequences and UTR(700)-Luc containing the CCAAT-1 sequence but lacking the CCAAT-2 sequence, luciferase activity remained at baseline level after stimulation with retinoic acid (Figure 4A). However, luciferase activity was markedly increased in the cells expressing UTR(614)-Luc after retinoic acid stimulation (Figure 4A). These results suggest that the CCAAT-2 motif plays an important role in inhibition of MARCKS transcription. Furthermore, the SH-SY5Y cells transfected with UTR(462)-Luc lacking CCAAT-1, CCAAT-2 and the Sp1 region showed very low luciferase activity (Figure 4A), indicating that Sp1 is indispensable for MARCKS transcription.
###end p 37
###begin title 38
Dysbindin regulates the transcription of MARCKS via the CCAAT2 sequence.
###end title 38
###begin p 39
###xml 1473 1474 1467 1468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
(A) The following five vectors were used for luciferase assay, containing shorter DNA probes; UTR(1152)-Luc, UTR (953)-Luc, UTR(700)-Luc, UTR(614)-Luc, and UTR(462)-Luc, were transfected into SH-SY5Y cells and Luciferase activity was measured. UTR(614), which lacks CCAAT1, showed increased luciferase activity. The luciferase activity of UTR(1152) was used as control. Columns and vertical bars denote the means +/- SEM (triplicate independent experiments). (B) UTR(1152)-Luc vector and deleted or point mutation of UTR(1152)-Luc vectors, [D1-UTR(1152)-Luc], [D2-UTR(1152)-Luc], [D3-UTR(1152)-Luc] [D4-UTR(1152)-Luc] and [M-UTR(1152)-Luc], were transfected into SH-SY5Y cells and Luciferase activity was measured. [D4-UTR(1152)-Luc], which lacks CCAAT2, and [M-UTR(1152)-Luc], which has a point mutation in the CCAAT2 sequence, showed increased luciferase activity. The luciferase activity of UTR(1152) was used as the control. Columns and vertical bars denote the means +/- SEM (triplicate independent experiments). (C and D) Scrambled RNAi-transfected SH-SY5Y cells and Dysbindin RNAi-transfected SH-SY5Y cells were transfected with the UTR(1152)-Luc vector (C) or D4-UTR(1152)-Luc (D) and Luciferase activity was measured. UTR(1152)-Luc vector-expressing cells showed the effect of Dysbindin expression levels on luciferase activity, but D4-UTR(1152)-Luc expressing cells did not. Columns and vertical bars denote the means +/- SEM (triplicate independent experiments; P<0.001, Student's t-test).
###end p 39
###begin p 40
###xml 65 71 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MARCKS</italic>
###xml 549 558 549 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g004">Figure 4B</xref>
###xml 755 764 755 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g004">Figure 4B</xref>
###xml 901 910 901 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g004">Figure 4B</xref>
###xml 978 984 978 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MARCKS</italic>
###xml 1245 1251 1245 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MARCKS</italic>
To confirm that the CCAAT-2 region is important in regulation of MARCKS transcription, we prepared several probes for the luciferase assay; D1-UTR(1152)-Luc which lacks the CCAAT-2 motif and its downstream region including Sp1 from UTR(1152)-Luc, D2-UTR(1152)-Luc which lacks the Sp1 region and downstream sequence from UTR(1152)-Luc, D3-UTR(1152)-Luc which lacks only sequence downstream of the Sp1 region, D4-UTR(1152)-Luc which lacks only the CCAAT-2 motif from UTR(1152)-Luc, and M-UTR(1152)-Luc which has a point mutation in the CCAAT-2 motif (Figure 4B). Luciferase activity was detected from the SH-SY5Y cells transfected with each probe, and luciferase activity detected in the cells transfected with UTR(1152)-Luc was used as the baseline value (Figure 4B). Cells transfected with M-UTR(1152)-Luc and those transfected with D4-UTR(1152)-Luc exhibited marked increases in luciferase activity (Figure 4B), showing that the CCAAT-2 motif plays a key role in inhibition of MARCKS transcription. Furthermore, cells expressing D1-UTR(1152)-Luc, D2-UTR(1152)-Luc or D3-UTR(1152)-Luc exhibited no luciferase activity. These findings suggest that the sequence downstream of the Sp1 region, as well as the Sp1 region itself, is indispensable for MARCKS transcription.
###end p 40
###begin p 41
###xml 55 61 55 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MARCKS</italic>
###xml 83 86 83 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 237 246 237 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g004">Figure 4C</xref>
###xml 488 497 488 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g004">Figure 4D</xref>
###xml 547 553 547 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MARCKS</italic>
###xml 568 571 568 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 848 854 848 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MARCKS</italic>
###xml 870 886 870 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g004">Figure 4A and 4B</xref>
To confirm the involvement of Dysbindin in the altered MARCKS transcription levels via the CCAAT-2 motif, we compared the luciferase activity of UTR(1152)-Luc detected in Dysbindin knockdown cells with that of control cells. As shown in Figure 4C, knockdown of Dysbindin resulted in upregulation of luciferase activity in the UTR(1152)-Luc transfected cells. However, the effect of knockdown of Dysbindin on luciferase activity was not observed in the D1-UTR(1152)-Luc transfected cells (Figure 4D). These results suggest that Dysbindin regulates MARCKS transcription via the CCAAT2 motif; the NF-YB binding site. On the other hand, since negligible levels of luciferase activity were observed in cells transfected with any of the probes lacking the sequence downstream of the Sp1 region, the sequence downstream of Sp1 appears to be essential for MARCKS transcription (Figure 4A and 4B).
###end p 41
###begin title 42
Discussion
###end title 42
###begin p 43
###xml 80 84 80 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Schwab1">[13]</xref>
###xml 86 90 86 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Corvin1">[30]</xref>
###xml 92 96 92 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Murotani1">[37]</xref>
###xml 98 102 98 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-vandenBogaert1">[53]</xref>
###xml 103 107 103 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Gornick1">[60]</xref>
###xml 251 255 251 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Talbot1">[26]</xref>
###xml 257 261 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Weickert1">[27]</xref>
###xml 457 460 457 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 206 214 <span type="species:ncbi:9606">patients</span>
Numerous reports support the role of Dysbindin in the etiology of schizophrenia [13], [30], [37], [53]-[60]. Previous studies have reported a decrease in Dysbindin expression in the brains of schizophrenic patients both at the mRNA and protein levels [26], [27]. However, the functional involvement of Dysbindin in the neural system is not yet well elucidated. In this study, we examined involvement of Dysbindin in neural transmission and neural formation via transcriptional regulation, because abnormalities in these neural processes are very important in the pathogenesis of schizophrenia.
###end p 43
###begin title 44
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MARCKS</italic>
Regulation of MARCKS Transcription by the Dysbindin/NF-YB Interaction
###end title 44
###begin p 45
###xml 129 137 129 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g001">Figure 1</xref>
###xml 142 143 142 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g002">2</xref>
###xml 211 217 211 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MARCKS</italic>
###xml 235 244 235 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g003">Figure 3C</xref>
###xml 351 359 351 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g004">Figure 4</xref>
###xml 417 423 417 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MARCKS</italic>
###xml 656 662 656 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MARCKS</italic>
###xml 829 835 829 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MARCKS</italic>
###xml 851 867 851 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g004">Figure 4A and 4B</xref>
###xml 19 24 <span type="species:ncbi:4932">yeast</span>
As a result of the yeast-two-hybrid assay and immunoprecipitation assay, we revealed an interaction between NF-YB and Dysbindin (Figure 1 and 2). In addition, we showed the binding of NF-YB and Dysbindin to the MARCKS promoter region (Figure 3C). These findings suggest involvement of this complex in transcriptional regulation of MARCKS. As shown in Figure 4, we found two CCAAT sequence motifs at the 5'-UTR of the MARCKS gene. Previous reports show that members of the NF-Y family including NF-YB bind to CCAAT sequences and can regulate transcription of a number of genes. Our results suggest that one of the CCAAT sequences, CCAAT-2, is important for MARCKS transcriptional regulation. On the other hand, our luciferase assay results suggest that both the Sp1 region and the sequence downstream of Sp1 are indispensable for MARCKS transcription (Figure 4A and 4B).
###end p 45
###begin title 46
###xml 52 59 52 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vivo</italic>
###xml 64 72 64 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vitro</italic>
Dysbindin Knockdown Increases MARCKS Protein Levels In Vivo and In Vitro
###end title 46
###begin p 47
###xml 32 38 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MARCKS</italic>
###xml 149 158 149 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g003">Figure 3A</xref>
###xml 250 259 250 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g003">Figure 3b</xref>
###xml 855 861 855 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MARCKS</italic>
###xml 1072 1081 1072 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g003">Figure 3b</xref>
###xml 1174 1183 1174 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g003">Figure 3b</xref>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 278 283 <span type="species:ncbi:10090">mouse</span>
###xml 538 543 <span type="species:ncbi:10090">mouse</span>
###xml 703 707 <span type="species:ncbi:10090">mice</span>
###xml 830 834 <span type="species:ncbi:10090">mice</span>
###xml 987 992 <span type="species:ncbi:10090">mouse</span>
###xml 1168 1172 <span type="species:ncbi:10090">mice</span>
###xml 1203 1207 <span type="species:ncbi:10090">mice</span>
###xml 1483 1487 <span type="species:ncbi:10090">mice</span>
In accordance with the enhanced MARCKS transcription mediated by the knockdown of Dysbindin, Dysbindin knockdown cells show increased MARCKS levels (Figure 3A). Next, we examined the expression level of MARCKS in Dysbindin knockout mice. As shown in Figure 3b, in the wild-type mouse brain the peak in MARCKS expression is at postnatal day 15; thereafter decreasing markedly with advancing age until only low levels of MARCKS expression are seen in adults (P45). Comparable alternations in MARCKS expression were also observed in another mouse line, ICR (data not shown). These findings support the hypothesis that MARCKS plays an important role in brain development. However, in the Dysbindin knockout mice, there is no effect on MARCKS expression during the developmental stage, when MARCKS is abundantly expressed in wild-type mice. During this stage, MARCKS transcription may be regulated by multiple molecules, which compensate for the lack of Dysbindin. With increasing age of the mouse, MARCKS expression decreases gradually to a low level of expression in adults (Figure 3b). In contrast, a decrease in MARCKS expression was not observed in Dysbindin knockout mice (Figure 3b) and even in adult mice brains, a high level of expression of MARCKS was detected. These findings show that Dysbindin likely plays a major role in regulation of MARCKS expression in the adult brain, in contrast to in the developmental stage. Therefore, considering the results in Dysbindin knockout mice, it is likely that MARCKS is expressed at high levels in schizophrenic brains, compared with age-matched control brains.
###end p 47
###begin title 48
MARCKS and Neural Transmission
###end title 48
###begin p 49
###xml 59 62 59 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 98 101 98 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 120 124 120 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Trifar1">[46]</xref>
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Park1">[48]</xref>
###xml 242 245 242 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Garver1">[1]</xref>
###xml 246 249 246 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Mouri1">[4]</xref>
###xml 638 642 638 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Kumamoto1">[39]</xref>
###xml 929 932 929 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
It has been shown that MARCKS impacts on neurotransmission via F-actin and on vesicular transport via synaptic vesicles [46]-[48]. Furthermore, many reports indicate that dopaminergic transmission is increased in the brains of schizophrenics [1]-[4]. Dopamine D2 antagonists are an effective treatment in schizophrenia, and dopamine-enhancing drugs mimic psychotic symptoms of schizophrenia. In the schizophrenic brain, the expression of Dysbindin is decreased, resulting in an increase in MARCKS protein expression, which impacts on neurotransmission. Furthermore, we found that decreases in Dysbindin levels upregulate dopamine release [39]. Therefore, the enhanced dopaminergic transmission produced by the lower expression level of Dysbindin may be partially attributable to activation of MARCKS. Thus, the impairment of neural transmission in the schizophrenic brain may be caused by alterations of MARCKS expression levels via changes in Dysbindin.
###end p 49
###begin title 50
###xml 40 43 40 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
Dysbindin May Regulate Neural Formation via Alteration of MARCKS Levels
###end title 50
###begin p 51
###xml 280 284 280 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Millar1">[61]</xref>
###xml 286 290 286 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Millar2">[62]</xref>
###xml 463 467 463 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Miyoshi1">[63]</xref>
###xml 511 515 511 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Hattori2">[64]</xref>
###xml 1060 1064 1060 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Kubota1">[40]</xref>
###xml 1318 1321 1318 1321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 1451 1453 1451 1453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">48</sup>
###xml 1553 1557 1553 1557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Trifar1">[46]</xref>
###xml 1559 1563 1559 1563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Sasaki1">[47]</xref>
###xml 1716 1719 1716 1719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
Many studies support the hypothesis that schizophrenia is a neurodevelopmental disease. Disrupted-In Schizophrenia 1 (DISC1) is a gene disrupted by a (1;1) (q42.1; q14.3) translocation that segregates with major psychiatric disorders, including schizophrenia in a Scottish family [61], [62]. Previously, we examined the physiological role of the molecular complex composed of DISC1 and its interacting partners, Fasciculation and elongation protein zeta 1 (Fez1) [63] and DISC1-Binding Zinc finger protein (DBZ)[64]. Both the DISC1-Fez1 interaction and the DISC1-DBZ interaction are involved in neurite extension. These reports suggest that abnormalities in the schizophrenia susceptibility genes, such as DISC1, likely cause an impairment of brain development resulting in schizophrenia. In addition, several reports suggest that the PKC signal is involved in psychiatric disorders, as well as other signals such as ERK, which play important roles in neural development. In addition, we previously showed the importance of Dysbindin for growth cone formation [40]. These previous reports suggest that abnormal neural formation could cause psychiatric disorders and that Dysbindin may be one of the important factors in normal neural development. In this study, we demonstrate the transcriptional regulation of MARCKS via Dysbindin and the upregulation of MARCKS by downregulation of Dysbindin. Since MARCKS is involved not only in neural transmission48 but also in neural developmental processes such as synaptogenesis and maintaining spine morphology [46], [47], these results suggest that dysfunction of Dysbindin likely causes the upregulation of MARCKS and may induce abnormal development of the nervous system via alterations of MARCKS levels.
###end p 51
###begin p 52
###xml 327 335 327 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 340 347 340 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 582 585 582 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 413 417 <span type="species:ncbi:10090">mice</span>
Thus, in this paper, we report the following findings; (1) Dysbindin interacts with NF-YB, (2) NF-YB and Dysbindin bind to the promoter region of MARCKS, (3) one of the CCAAT sequences is likely essential for the transcriptional regulation of MARCKS and (4) the downregulation of Dysbindin upregulates the expression of MARCKS in vitro and in vivo. On the other hand, we previously showed that Dysbindin knockout mice exhibit schizophrenia-like behavior and abnormalities of the dopaminergic system. These phenotypes may be at least partly attributable to over-activation of MARCKS via a decrease in Dysbindin levels.
###end p 52
###begin p 53
In conclusion, these results may help shed some light on the causes of schizophrenia, and indicate that the transcriptional regulation of Dysbindin may contribute to schizophrenia. Further studies of Dysbindin and its association with MARCKS and with schizophrenia may reveal novel treatment targets for schizophrenia.
###end p 53
###begin title 54
Materials and Methods
###end title 54
###begin title 55
Antibodies
###end title 55
###begin p 56
###xml 68 73 <span type="species:ncbi:9606">human</span>
###xml 608 613 <span type="species:ncbi:10090">mouse</span>
###xml 618 624 <span type="species:ncbi:9986">Rabbit</span>
###xml 675 680 <span type="species:ncbi:10090">mouse</span>
Monoclonal anti-Dysbindin antibody was produced. Briefly, GST-fused human Dysbindin was used as antigen and the Dysbindin protein for ELISA was made by thrombin digestion of GST-Dysbindin. High-titer clones for Dysbindin were selected by ELISA using the Dysbindin protein and the immunoreactivity of the clones was checked by Western blot. Antibodies of anti-GFP (Santa Cruz Biotechnology, Santa Cruz, CA), anti-Flag (Sigma-Aldrich, St Louis, MO), anti-V5 (Invitrogen), anti-beta-actin (Chemicon International, Temecula, CA), anti-NF-YB (Santa Cruz Biotechnology), anti-MARCKS (Upstate), HRP-conjugated anti-mouse and Rabbit IgG (Cell Signaling Technology, Beverly, MA), and mouse normal IgG (Sigma-Aldrich) were purchased commercially.
###end p 56
###begin title 57
Plasmids
###end title 57
###begin p 58
###xml 99 108 99 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dysbindin</italic>
###xml 145 149 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008773-Morris1">[22]</xref>
###xml 544 619 544 619 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;&#8722;CTCGAGTTACGTAGAATCGAGACCGAGGAGAGGGTTAGGGATAGGCTTACCAGAGTCGCTGTCCTCACC&#8722;3&#8242;</named-content>
###xml 634 672 634 672 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;&#8722;GGTACCGCCACCATGCTGGAGACCCTTCGCGA&#8722;3&#8242;</named-content>
###xml 691 733 691 733 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;&#8722;GCTAGCGCCACCATGACAATGGATGGTGACAGTTCT&#8722;3&#8242;</named-content>
###xml 748 781 748 781 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;&#8722;GATATCTGAAAACTGAATTTGCTGAAC&#8722;3&#8242;</named-content>
###xml 93 98 <span type="species:ncbi:9606">human</span>
###xml 155 160 <span type="species:ncbi:9606">human</span>
###xml 293 298 <span type="species:ncbi:9606">human</span>
We previously constructed the pEGFP-C1 expression vector (Clontech) carrying the full-length human Dysbindin cDNA (-GFP is tagged to N-terminal) [22]. The human Dysbindin-V5 (-V5 is tagged to C-terminal), Dysbindin-FLAG (-FLAG is tagged to N-terminal) and NF-YB moieties were amplified from a human brain cDNA library using PCR and subcloned into pcDNA3.1 (+) expression vector (Invitrogen, Carlsbad, CA). Dysbindin and NF-YB were amplified using rTaq DNA polymerase (Takara Bio Inc., Kyoto, Japan) with the following primer set: Dysbindin-V5, 5'-CTCGAGTTACGTAGAATCGAGACCGAGGAGAGGGTTAGGGATAGGCTTACCAGAGTCGCTGTCCTCACC-3' (forward) and 5'-GGTACCGCCACCATGCTGGAGACCCTTCGCGA-3' (reverse); NF-YB, 5'-GCTAGCGCCACCATGACAATGGATGGTGACAGTTCT-3' (forward) and 5'-GATATCTGAAAACTGAATTTGCTGAAC-3' (reverse). The amplified fragments were TA cloned into the pGEM-T vector (Promega Corp.).
###end p 58
###begin p 59
###xml 417 433 381 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008773-g002">Figure 2B and 2D</xref>
pMARCKS-Luc(-1152) was generated by subcloning promoters into pGL3-(R2.2) Basic (Promega). We generated 5' deletion constructs of pMARCKS-Luc(-1152) and an internal deletion construct of the region -700approximately-1. Other deletion constructs of the region (-231approximately-150) and point mutation constructs of pMARCKS-Luc/dl(-204approximately-187), were generated by inserting double-stranded oligonucleotides (Figure 2B and 2D). The plasmid pMARCKS-Luc(-736/mt) was generated by site-directed mutagenesis, which changed the same nucleotides as those of mutant 5.
###end p 59
###begin title 60
Cell Culture
###end title 60
###begin p 61
###xml 370 371 364 365 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 57 62 <span type="species:ncbi:9606">Human</span>
###xml 296 302 <span type="species:ncbi:9913">bovine</span>
Human neuroblastoma SH-SY5Y cells were obtained from the Human Science Research Resources Bank (HSRRB). These cells were maintained in tissue culture dishes (Nalge Nunc, Rochester, NY, USA) in 50% minimal essential medium (Invitrogen) /50% F-12 (Invitrogen) containing 15% heat-inactivated fetal bovine serum (Invitrogen) at 37degreesC in an atmosphere of 95% air /5% CO2.
###end p 61
###begin title 62
Animals
###end title 62
###begin p 63
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sdy</italic>
###xml 4 8 <span type="species:ncbi:10090">mice</span>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
###xml 164 168 <span type="species:ncbi:10090">mice</span>
###xml 272 277 <span type="species:ncbi:10090">mouse</span>
sdy mice (Dysbindin KO mice) and wild-type littermates were provided by the Takeda lab, Department of Psychiatry, Osaka University Graduate School of Medicine. The mice were deeply anesthetized with sodium pentobarbital. Brains (hippocampus) were dissected from each aged mouse. All animal experiments were carried out in accordance with a protocol approved by the Institutional Animal Care and Use Committee of Osaka University.
###end p 63
###begin title 64
Immunocytochemistry
###end title 64
###begin p 65
###xml 91 92 91 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 101 102 101 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 250 254 <span type="species:ncbi:9925">goat</span>
SY5Y cells were grown on poly-l-lysine-coated four-well chamber dishes at a density of 3x104 cells/cm2. The cells were fixed in 2% paraformaldehyde in 0.1 M PBS, permeabilized, and blocked with 0.02 M PBS containing 0.3% Triton X-100, 3% BSA and 10% goat serum for 30 min at room temperature, and then incubated with antibodies specific for the individual protein. Confocal microscopy was performed using a Carl Zeiss LSM-510 confocal microscope.
###end p 65
###begin title 66
Fractionation Assay
###end title 66
###begin p 67
###xml 323 324 323 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
Cells were collected after washing with ice-cold PBS. Cells and brains were homogenized in Tris buffer (20 mM Tris-HCl, pH 7.8, 1 mM EDTA, 150 mM NaCl and protease inhibitor cocktail (Roche)). After homogenization, the homogenized proteins were lysed by the addition of 0.5% NP-40 for 30 min on ice and centrifuged at 500 xg for 10 min to collect the nuclear pellet. The supernatant was collected as the cytosolic fraction.
###end p 67
###begin title 68
Immunoprecipitation (IP)
###end title 68
###begin p 69
###xml 347 348 341 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
After washing cells with ice-cold PBS, cells were collected and resuspended in 1 mL lysis buffer (20 mM Tris-HCl, pH 7.8, 0.2% NP-40, 1 mM EDTA, 150 mM NaCl and protease inhibitor cocktail (Roche)). Cells were frozen in dry ice/EtOH and stored at -80degreesC. Cell lysates were incubated on ice for 30 min and then centrifuged for 5 min at 13,600xg. After centrifugation, the supernatants were precleared with protein Sepharose G beads and IP was carried out in lysis buffer with antibody/protein G Sepharose beads for 1 h at 4degreesC. After washing in lysis buffer, immunoprecipitated proteins were immunoblotted.
###end p 69
###begin title 70
Immunoblotting
###end title 70
###begin p 71
Aliquots of whole cell lysates or IP lysates separated by SDS-PAGE were blotted onto an Immobilon-P membrane (Millipore), and then incubated with antibodies specific for individual protein. Proteins were detected by ECL plus Western Blotting Detection System (GE Healthcare), followed by exposure to X-ray films according to the manufacturer's protocol.
###end p 71
###begin title 72
Knockdown Experiment Using Small Interfering RNA (siRNA)
###end title 72
###begin p 73
###xml 33 64 33 64 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;&#8722;CCAAAGUACUCUGCUGGAUUAGAAU&#8722;3&#8242;</named-content>
###xml 69 100 69 100 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;&#8722;GCUCCCAGCUUUAAUCGCAGACUUA&#8722;3&#8242;</named-content>
###xml 110 141 110 141 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;&#8722;UACUGAGGACAGCAUGAAUGAUCAU&#8722;3&#8242;</named-content>
###xml 206 237 206 237 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;&#8722;CCATGATCTCGTCGTTAGAAAGAAA&#8722;3&#8242;</named-content>
###xml 242 273 242 273 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;&#8722;GCTACCGTTATTAGCACAGCCCTTA&#8722;3&#8242;</named-content>
###xml 307 338 307 338 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;&#8722;UACGGAACAACGAGUGUAUAUGCAU&#8722;3&#8242;</named-content>
Stealth siRNA against Dysbindin (5'-CCAAAGUACUCUGCUGGAUUAGAAU-3' and 5'-GCUCCCAGCUUUAAUCGCAGACUUA-3' ), NF-YB 5'-UACUGAGGACAGCAUGAAUGAUCAU-3' , and negative control duplexes (scrambled siRNA for Dysbindin, 5'-CCATGATCTCGTCGTTAGAAAGAAA-3' and 5'-GCTACCGTTATTAGCACAGCCCTTA-3' ; and scrambled siRNA for NF-YB, 5'-UACGGAACAACGAGUGUAUAUGCAU-3' ) were provided by Invitrogen Corp. SY5Y cells were transfected with 100 pM of each siRNA and scrambled siRNA using Lipofectamine 2000 (Invitrogen Corp.) according to the manufacturer's instructions.
###end p 73
###begin title 74
RNA Extracts and Microarray
###end title 74
###begin p 75
###xml 561 566 <span type="species:ncbi:9606">Human</span>
Total RNA was extracted from cells using RNeasy columns (Qiagen) according to the manufacturer's instructions. Five hundred nanograms of total RNA from control and experimental cells was separately amplified and labeled with either Cy3- or Cy5-labeled CTP (Perkin Elmer) with an Agilent low input linear amplification kit (Agilent Technologies) according to manufacturer's instructions. After labeling and cleanup, amplified RNA was quantified by UV-vis spectroscopy. One microgram each of Cy3- and Cy5-labeled targets were combined and hybridized with a Whole Human Genome Oligo Microarray Kit (G4112F)according to the manufacturer's instructions. Three biological replicates were used at each time point with one of the replicates being a dye reversal of the other two. Microarrays were imaged on a Hitachi image scanner and data analyzed with GeneSpring 6 (Silicon Genetics).
###end p 75
###begin title 76
Chromatin Immunoprecipitation (ChIP) Assay
###end title 76
###begin p 77
###xml 545 575 539 569 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;&#8722;GGTTTGCTCTTTGATGCTCTTGAT&#8722;3&#8242;</named-content>
###xml 580 605 574 599 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;&#8722;ACTTTCGGGTGGGGTGTAA&#8722;3&#8242;</named-content>
ChIP analysis was performed using a Chromatin Immunoprecipitation Assay Kit (Upstate Biotechnology) according to the manufacturer's instructions. Briefly, protein-DNA complexes were crosslinked with 1% formaldehyde (10 min at room temperature) and cells were harvested. DNA was sonicated to lengths of 500-1000 bp. Antibodies specific for individual protein were used for immunoprecipitating protein-DNA complexes overnight at 4degreesC. PCR was performed with individual specific primer sets for the MARCKS promoter: the proximal CCAAT region, 5'-GGTTTGCTCTTTGATGCTCTTGAT-3' and 5'-ACTTTCGGGTGGGGTGTAA-3'
###end p 77
###begin title 78
Reporter Assay
###end title 78
###begin p 79
Reporter plasmids were transfected into cells using Lipofectamine 2000 (Invitrogen) together with phRG-TK (Renilla reporter for internal control) which monitored transfection efficiency. Luciferase activities were assayed using the Dual Luciferase Assay System (Promega). All assays were performed three times in duplicate and values are shown as means +/- SD.
###end p 79
###begin title 80
Supporting Information
###end title 80
###begin p 81
The preparation of mRNAs for microarray analysis. (A-(a) and B-(a)) To prepare RNAs for microarrays analysis, we transfected the siRNA for Dysbindin, NF-YB, or scrambled as a control. The effect of each RNAi was confirmed by Western blot using the antibody for Dysbindin or NF-YB. (A-(b) and B-(b)) The columns and vertical bars denote the means +/- SEM (triplicate independent experiments; P<0.001, Student's t-test). Dysbindin or NF-YB was knocked-down significantly by transfection of the siRNA for Dysbindin or NF-YB, compared with the control.
###end p 81
###begin p 82
(1.10 MB EPS)
###end p 82
###begin p 83
Click here for additional data file.
###end p 83
###begin p 84
We thank Ms. Arakawa, Ms. Moriya, and Ms. Ohashi for preparing our experiments.
###end p 84
###begin title 85
References
###end title 85
###begin article-title 86
Evolution of antipsychotic intervention in the schizophrenic psychosis.
###end article-title 86
###begin article-title 87
Pathophysiologically based treatment interventions in schizophrenia.
###end article-title 87
###begin article-title 88
Neurobiology of schizophrenia.
###end article-title 88
###begin article-title 89
Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment.
###end article-title 89
###begin article-title 90
###xml 40 48 <span type="species:ncbi:9606">patients</span>
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
###end article-title 90
###begin article-title 91
Glutamate and schizophrenia: Beyond the dopamine hypothesis.
###end article-title 91
###begin article-title 92
NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders.
###end article-title 92
###begin article-title 93
The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity.
###end article-title 93
###begin article-title 94
Bringing order to the glutamate chaos in schizophrenia.
###end article-title 94
###begin article-title 95
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
Dopamine receptor excess and mouse madness.
###end article-title 95
###begin article-title 96
Synaptic plasticity and dysconnection in schizophrenia.
###end article-title 96
###begin article-title 97
###xml 49 54 <span type="species:ncbi:9606">human</span>
###xml 71 76 <span type="species:ncbi:10090">mouse</span>
Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia.
###end article-title 97
###begin article-title 98
Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families.
###end article-title 98
###begin article-title 99
Neuregulin 1 and susceptibility to schizophrenia.
###end article-title 99
###begin article-title 100
Association of neuregulin 1 with schizophrenia confirmed in a Scottish population.
###end article-title 100
###begin article-title 101
Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia.
###end article-title 101
###begin article-title 102
Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia.
###end article-title 102
###begin article-title 103
A highly significant association between a COMT haplotype and schizophrenia.
###end article-title 103
###begin article-title 104
Association and linkage analyses of RGS4 polymorphisms in schizophrenia.
###end article-title 104
###begin article-title 105
Support for RGS4 as a susceptibility gene for schizophrenia.
###end article-title 105
###begin article-title 106
Regulator of G-protein signaling 4 (RGS4) gene is associated with schizophrenia in Irish high density families.
###end article-title 106
###begin article-title 107
Confirming RGS4 as a susceptibility gene for schizophrenia.
###end article-title 107
###begin article-title 108
Evidence for a susceptibility locus for schizophrenia on chromosome 6pter-p22.
###end article-title 108
###begin article-title 109
A potential vulnerability locus for schizophrenia on chromosome 6p24-22: evidence for genetic heterogeneity.
###end article-title 109
###begin article-title 110
Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain.
###end article-title 110
###begin article-title 111
Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia.
###end article-title 111
###begin article-title 112
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain.
###end article-title 112
###begin article-title 113
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
Effect of antipsychotic drugs on DISC1 and dysbindin expression in mouse frontal cortex and hippocampus.
###end article-title 113
###begin article-title 114
Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression.
###end article-title 114
###begin article-title 115
A dysbindin risk haplotype associated with less severe manic-type symptoms in psychosis.
###end article-title 115
###begin article-title 116
Variance in neurocognitive performance is associated with dysbindin-1 in schizophrenia: a preliminary study.
###end article-title 116
###begin article-title 117
Genetic variation in DTNBP1 influences general cognitive ability.
###end article-title 117
###begin article-title 118
Variation in the dysbindin gene and normal cognitive function in three independent population samples.
###end article-title 118
###begin article-title 119
###xml 84 92 <span type="species:ncbi:9606">patients</span>
Association between the DTNBP1 gene and intelligence: a case-control study in young patients with schizophrenia and related disorders and unaffected siblings.
###end article-title 119
###begin article-title 120
###xml 76 81 <span type="species:ncbi:10090">mouse</span>
Abnormal dysbindin expression in cerebellar mossy fiber synapses in the mdx mouse model of Duchenne muscular dystrophy.
###end article-title 120
###begin article-title 121
Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia.
###end article-title 121
###begin article-title 122
###xml 46 50 <span type="species:ncbi:10090">mice</span>
High dopamine turnover in the brains of Sandy mice.
###end article-title 122
###begin article-title 123
###xml 63 67 <span type="species:ncbi:10090">mice</span>
Behavioral abnormalities and dopamine reductions in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia.
###end article-title 123
###begin article-title 124
Hyperactivation of Midbrain Dopaminergic System in Schizophrenia could be attributed to the Down-regulation of Dysbindin.
###end article-title 124
###begin article-title 125
Dysbindin engages in c-Jun N-terminal kinase activity and cytoskeletal organization.
###end article-title 125
###begin article-title 126
Dynamic recruitment of transcription factors and epigenetic changes on the ER stress response gene promoters.
###end article-title 126
###begin article-title 127
Requirement for down-regulation of the CCAAT-binding activity of the NF-Y transcription factor during skeletal muscle differentiation.
###end article-title 127
###begin article-title 128
###xml 0 7 <span type="species:ncbi:8355">Xenopus</span>
###xml 101 108 <span type="species:ncbi:8355">Xenopus</span>
Xenopus NF-Y pre-sets chromatin to potentiate p300 and acetylation-responsive transcription from the Xenopus hsp70 promoter in vivo.
###end article-title 128
###begin article-title 129
Role of the CCAAT-binding protein CBF/NF-Y in transcription.
###end article-title 129
###begin article-title 130
RNF151, a testis-specific RING finger protein, interacts with dysbindin.
###end article-title 130
###begin article-title 131
Two pathways control chromaffin cell cortical F-actin dynamics during exocytosis.
###end article-title 131
###begin article-title 132
New aspects of neurotransmitter release and exocytosis: Rho-kinase-dependent myristoylated alanine-rich C-kinase substrate phosphorylation and regulation of neurofilament structure in neuronal cells.
###end article-title 132
###begin article-title 133
Involvement of protein kinase C-epsilon in activity-dependent potentiation of large dense-core vesicle exocytosis in chromaffin cells.
###end article-title 133
###begin article-title 134
Synaptically driven endocannabinoid release requires Ca2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase Cbeta4 signaling cascade in the cerebellum.
###end article-title 134
###begin article-title 135
Synaptotagmin I, a Ca2+ sensor for neurotransmitter release.
###end article-title 135
###begin article-title 136
Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness.
###end article-title 136
###begin article-title 137
###xml 128 136 <span type="species:ncbi:9606">patients</span>
Levels of mRNAs encoding synaptic vesicle and synaptic plasma membrane proteins in the temporal cortex of elderly schizophrenic patients.
###end article-title 137
###begin article-title 138
The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease.
###end article-title 138
###begin article-title 139
Family-based association study of DTNBP1 in 6p22.3 and schizophrenia.
###end article-title 139
###begin article-title 140
Identification of a high-risk haplotype for the dystrobrevin binding protein 1(DTNBP1) gene in the Irish study of high-density schizophrenia families.
###end article-title 140
###begin article-title 141
Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1).
###end article-title 141
###begin article-title 142
Association of the DTNBP1 locus with schizophrenia in a U.S. population.
###end article-title 142
###begin article-title 143
Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria.
###end article-title 143
###begin article-title 144
Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia.
###end article-title 144
###begin article-title 145
Dysbindin (DTNBP1, 6p22.3) is Associated with Childhood-Onset Psychosis and Endophenotypes Measured by the Premorbid Adjustment Scale (PAS).
###end article-title 145
###begin article-title 146
Disruption of two novel genes by a translocation co-segregating with schizophrenia.
###end article-title 146
###begin article-title 147
Genomic structure and localisation within a linkage hotspot of Disrupted In Schizophrenia 1, a gene disrupted by a translocation segregating with schizophrenia.
###end article-title 147
###begin article-title 148
###xml 0 28 0 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Disrupted-In-Schizophrenia 1</italic>
Disrupted-In-Schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth.
###end article-title 148
###begin article-title 149
A novel DISC1-interacting partner DISC1-Binding Zincfinger protein: implication in the modulation of DISC1-dependent neurite outgrowth.
###end article-title 149
###begin p 150
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 150
###begin p 151
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants from the Osaka Medical Research Foundation For Incurable Diseases (Shinsuke Matsuzaki) and the Twenty-First Century Center of Excellence (COE) program and the Global COE program (Hiroaki Okuda, Ryusuke Kuwahara, Shinsuke Matsuzaki, Shingo Miyata, Natsuko Kumamoto, Tsuyoshi Hattori, Shoko Shimizu, Kohei Yamada, Taiichi Katayama and Masaya Tohyama). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 151

